RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2022 - $689,966
2021 - $749,812
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Matthew J. Sikora, PhD
2021
$30,000
Targeting an unexplored DNA repair deficiency and radiosensitivity in lobular breast cancer
John Tentler, PhD
2021
$30,000
Cancer Research Summer Fellowship Program
Satyanarayan Rao, PhD
2021
$30,000
Using transcription factors to map tumor state and microenvironment
Adam Green, MD and Natalie Serkova, PhD and Mark Borden, PhD
2021
$60,000
MRI-Guided Focused Ultrasound to Improve Treatment of DIPG
Rajeev Vibhakar, MD, PhD, MPH
2021
$30,000
Role of BMI1 in SMARB1 deleted ATRTs
Santos Franco, PhD, Siddhartha Mitra, PhD and Adam Green, MD
2021
$60,000
Development of In utero driven Mouse Models of Diffused Midline Gliomas to study the tumor immune interactions in Pediatric Midline Gliomas
Masanori Hayashi, MD
2021
$30,000
Preclinical Investigation of BCOR rearranged solid tumors
Elizabeth Kessler, MD
2021
$29,812
Validation of a patient-reported tool to screen for geriatric impairments predictive of potential frailty in cancer patients
Andrew Getahun, PhD and John Cambier, PhD
2021
$60,000
Identification of novel inhibitory checkpoint receptors
Nathan Dahl, MD
2021
$30,000
Unlocking the combination: Potentiation of radiation-induced antitumor effect using clinically-relevant BH3 mimetics to effectively target DIPG
Carol Sartorius, PhD
2021
$30,000
Lipodependence of endocrine resistant breast cancer as a therapeutic target
Alisa Lee-Sherick, MD and C. Wyatt Shields, PhD
2021
$60,000
Assessment of Cell Types for Delivering MerTK Inhibitors to Sarcomas
Carlo Marchetti, PhD and Mayumi Fujita, MD, PhD
2021
$60,000
Identifying the role of NLRP3 in immunotherapy resistant melanomas
Siddhartha Mitra, PhD
2021
$30,000
Development of Chimeric Antigen Receptor Expressing macrophages and microglia to target pediatric glioblastoma
Takeshi Yamauchi, PhD
2021
$30,000
Non-UV risk factors of melanoma
Leonora Slatnick, MD
2021
$30,000
Biomarker Development for Sepsis in Pediatric Oncology Patients
Paul Jedlicka, MD, PhD
2021
$30,000
Understanding the metastasis-promoting cistrome in Ewing Sarcoma
Jennifer Matsuda, PhD and James Scott-Browne, PhD
2021
$60,000
Genetic manipulation of human T cell transcriptional programs to improve cancer immunotherapy
Sujatha Venkataraman, PhD
2021
$30,000
Novel CAR T cell therapies to target metastatic Ewing Sarcoma
Ryan Marker, PhD
2020
$ 30,000
Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors
Maureen Lynch, Phd & Philip Owens, PhD
2020
$ 60,000
The role of exercise in breast cancer bone metastasis
Senthilnath Lakshmana Chetty, PhD
2020
$ 30,000
Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation
Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD
2020
$ 60,000
Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells
Zachary Graff, MD
2020
$ 30,000
Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia
Zdenek Andrysik PhD
2020
30,000
Exploring strong synergism of targeted p53 activation and translation inhibition in colorectal cancer.
Christine Towers, PhD
2020
$ 30,000
Identifying novel regulators of mitochondrial turn over
Matthew Tallaferro, PhD
2020
$ 30,000
Control of cell division through centrosomal RNA localization
Paula Jedlicka, MD, PhD
2020
$ 30,000
Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma
Diana M. Cittelly, PhD
2020
$ 30,000
Function of Ephrin B Signaling in Breast cancer brain metastasis
Rebecca Schweppe, PhD
2020
$ 30,000
The role of Nuclear FAK in Thyroid Cancer
Breelyn Wilky, MD & Eduardo Davila, PhD
2020
$ 60,000
Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma
Molishree Joshi, PhD
2020
$ 30,000
A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma
Swati G. Patel, MD, MS
2020
$ 30,000
Identification of Hereditary Cancer Syndromes through Advanced Polyps
Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD
2020
$ 60,000
The role of alpha-1 antitrypsin in cancer immunotherapy
Raphael Nemenoff, PhD & Erin Schenk, MD, PhD
2020
$ 60,000
The Tumor Microenvironment as a Critical Regulator of Targeted Therapy in ALK Positive Lung Cancer
Matthew Sikora, PhD
2019
$ 30,000
Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma
Heather Brechbuhl, PhD
2019
$ 30,000
Defining reversible tumor traits in the obese microenvironment
Isabel Schlaepfer, PhD
2019
$ 30,000
Role of fat oxidation via CPT1A in immunological response to prostate cancer
Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD
2019
$ 60,000
Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma
Cem Altunbas, PhD
2019
$ 30,000
High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy
Jay Hesselberth, PhD
2019
$ 30,000
Single-cell methods to measure functional heterogeneity
John Tentler, PhD
2019
$ 30,000
Cancer Research Summer Fellowship Program
Neil Box, PhD
2019
$ 30,000
Regulation of p53 in tanning
Adam Mueller, MD, PhD
2019
$ 30,000
Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer
Yiqun Shellman, PhD & Martin McCarter, MD
2019
$ 60,000
Targeting anti-apoptotic pathways to improve immunotherapies for melanoma
Stephen Keysar, PhD
2019
$ 30,000
Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation
Zachary Levi Watson, PhD
2019
$ 30,000
Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer
Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD
2019
$ 60,000
CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG
Mayumi Fujita, MD, PhD & Donald Backos, PhD
2019
$ 60,000
Somatic mutations in inflammasome genes in melanoma
Carol Sartorius, PhD
2019
$ 30,000
PR-RAR downregulation of protein synthesis and cell growth in breast cancer
Rajeev Vibhakar, MD, PhD, MPH
2019
$ 30,000
Role of CDK7 in medulloblastoma
Shi-Long Lu, MD, PhD and Daniel Frank, PhD
2019
$ 60,000
Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy
Paul Norman, PhD
2019
$ 30,000
Natural Killer cells can protect from developing leukemia
Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD
2018
$ 60,000
Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma
Adwitiya Kar, PhD and Margaret Wierman, MD
2018
$ 30,000
Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma
Jessica Lake, MD, MPH
2018
$ 30,000
IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas
Courtney Jones, PhD
2018
$ 30,000
Targeting relapse leukemia stem cells through inhibition of NAD synthesis
Christopher Lieu, MD and Todd Pitts, MD
2018
$ 60,000
Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer
Benjamin Bitler, PhD
2018
$ 30,000
Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance
Linda Van Dyk, PhD
2018
$ 30,000
Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis
Raul M. Torres, PhD
2018
$ 30,000
Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid
Nicholas Forman, MD
2018
$ 30,000
Characterization of heterogeneous tumor subpopulations in childhood ependymoma
Jennifer DeLuca, PhD
2018
$ 30,000
Targeting Kinetochore Dysfunction in Cancer Cells
Martin McCarter, MD
2018
$ 30,000
Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function
Jennifer Hintzsche, PhD
2018
$ 30,000
Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer
David Thomas, PhD and Mark Borden, PhD
2018
$ 30,000
X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy
Maria Jose Contreras, PhD
2018
$ 30,000
Mechanisms of TDM1/radiation-induced toxicity in brain metastases
Mair E.A. Churchill, PhD
2018
$ 30,000
Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis
Zhangguo Chen, PhD
2018
$ 30,000
Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy
Scott Cramer, PhD and James Costello, PhD
2018
$ 60,000
Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7
Jill Slansky PhD
2018
$ 30,000
Functional activation of low-affinity T cells in the tumor
Rebecca Schweppe, PhD
2018
$ 30,000
Cooperative Src and MAP Kinase Signaling in Thyroid Cancer
David Ryan Ormond MD
2018
$ 30,000
Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety
Nathan Dahl, MD
2018
$ 30,000
Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma
John Tentler, PhD
2018
$ 30,000
Cancer Research Summer Fellowship Program